{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:54:03Z","timestamp":1789746843339,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.blre.2010.01.002","type":"journal-article","created":{"date-parts":[[2010,2,20]],"date-time":"2010-02-20T09:39:09Z","timestamp":1266658749000},"page":"83-90","source":"Crossref","is-referenced-by-count":11,"title":["Significance of JAK2 and TET2 mutations in myelodysplastic syndromes"],"prefix":"10.1016","volume":"24","author":[{"given":"Eva","family":"Hellstr\u00f6m-Lindberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2010.01.002_bib1","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1182\/blood.V99.12.4638","article-title":"Narrowing and genomic annotation of the commonly deleted region of the 5q\u2212 syndrome","volume":"99","author":"Boultwood","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature06494","article-title":"Identification of RPS14 as a 5q\u2212 syndrome gene by RNA interference screen","volume":"451","author":"Ebert","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.blre.2010.01.002_bib3","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.blre.2010.01.002_bib4","series-title":"WHO classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.blre.2010.01.002_bib5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0145-2126(00)00088-6","article-title":"Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients","volume":"24","author":"Germing","year":"2000","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2010.01.002_bib6","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3324\/haematol.11051","article-title":"Chronic myelomonocytic leukemia in the light of the WHO proposals","volume":"92","author":"Germing","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2010.01.002_bib8","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","article-title":"Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making","volume":"23","author":"Malcovati","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2010.01.002_bib9","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2006.08.5696","article-title":"Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes","volume":"25","author":"Malcovati","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2010.01.002_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.blre.2007.10.003","article-title":"Supportive care, growth factors, and new therapies in myelodysplastic syndromes","volume":"22","author":"Hellstrom-Lindberg","year":"2008","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2010.01.002_bib11","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1182\/blood-2002-07-2006","article-title":"Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia","volume":"101","author":"Cazzola","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib12","author":"Cazzola","year":"2005"},{"key":"10.1016\/j.blre.2010.01.002_bib13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.seminhematol.2009.07.001","article-title":"Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment","volume":"46","author":"Camaschella","year":"2009","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2010.01.002_bib14","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1046\/j.1365-2141.2000.01940.x","article-title":"Two types of acquired idiopathic sideroblastic anaemia (AISA): a time-tested distinction","volume":"108","author":"Germing","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.01.002_bib15","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1182\/blood-2003-06-2124","article-title":"The WHO classification of MDS does make a difference","volume":"103","author":"Howe","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib16","first-page":"392","article-title":"Essential thrombocythemia with ringed sideroblasts: a heterogeneous spectrum of diseases, but not a distinct entity","volume":"87","author":"Schmitt-Graeff","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2010.01.002_bib17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ng.359","article-title":"Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia","volume":"41","author":"Guernsey","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.blre.2010.01.002_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s100380050051","article-title":"Cloning and chromosomal mapping of a novel ABC transporter gene (hABC7), a candidate for X-linked sideroblastic anemia with spinocerebellar ataxia","volume":"43","author":"Shimada","year":"1998","journal-title":"J Hum Genet"},{"key":"10.1016\/j.blre.2010.01.002_bib20","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1182\/blood-2006-04-015768","article-title":"Abcb7, the gene responsible for X-linked sideroblastic anemia with ataxia, is essential for hematopoiesis","volume":"109","author":"Pondarre","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib21","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1182\/blood-2006-08-041632","article-title":"RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload","volume":"109","author":"Cavadini","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib22","doi-asserted-by":"crossref","first-page":"e1970","DOI":"10.1371\/journal.pone.0001970","article-title":"The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts","volume":"3","author":"Boultwood","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2010.01.002_bib23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.leukres.2006.06.005","article-title":"Candidate gene mutation analysis in idiopathic acquired sideroblastic anemia (refractory anemia with ringed sideroblasts)","volume":"31","author":"Steensma","year":"2007","journal-title":"Leuk Res"},{"issue":"Suppl. 2","key":"10.1016\/j.blre.2010.01.002_bib24","first-page":"99","article-title":"New insights into the biology of refractory anemia with ring sideroblasts (RARS) and identification of erythroid G-CSF targets by gene expression profiling","volume":"94","author":"Nikpour","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2010.01.002_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/blood-2005-12-4769","article-title":"Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype","volume":"108","author":"Pellagatti","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0145-2126(00)00151-X","article-title":"Mitochondrial disruption and limited apoptosis of erythroblasts are associated with high risk myelodysplasia. An ultrastructural analysis","volume":"25","author":"van de Loosdrecht","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2010.01.002_bib27","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1182\/blood-2002-06-1825","article-title":"Mitochondrial DNA mutations in patients with myelodysplastic syndromes","volume":"101","author":"Shin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib28","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2003-07-2446","article-title":"Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome","volume":"103","author":"Gattermann","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib29","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1182\/blood-2002-06-1774","article-title":"Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors","volume":"101","author":"Tehranchi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib30","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1182\/blood-2004-08-3166","article-title":"Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD","volume":"105","author":"Claessens","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/blood-2004-12-4649","article-title":"Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes","volume":"106","author":"Tehranchi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib32","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1046\/j.1365-2141.2001.02581.x","article-title":"Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases","volume":"112","author":"Hellstrom-Lindberg","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.01.002_bib33","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2009-05-222331","article-title":"Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis","volume":"114","author":"Malcovati","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib34","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.blre.2010.01.002_bib35","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia","volume":"3","author":"Pikman","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.blre.2010.01.002_bib36","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis","volume":"356","author":"Scott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2010.01.002_bib37","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood-2006-02-005751","article-title":"Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation","volume":"108","author":"Szpurka","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib38","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2006-03-008227","article-title":"The JAK2\u2013V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS)","volume":"108","author":"Boissinot","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib39","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1038\/sj.leu.2404373","article-title":"The JAK2 V617F mutation is rare in RARS but common in RARS-T","volume":"20","author":"Ceesay","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2010.01.002_bib40","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/sj.leu.2404215","article-title":"The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow","volume":"20","author":"Ingram","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2010.01.002_bib41","first-page":"719","article-title":"Occurrence of the JAK2 V617F mutation in the WHO provisional entity: myelodysplastic\/myeloproliferative disease, unclassifiable-refractory anemia with ringed sideroblasts associated with marked thrombocytosis","volume":"91","author":"Remacha","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2010.01.002_bib42","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/sj.leu.2404405","article-title":"High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis","volume":"20","author":"Renneville","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2010.01.002_bib43","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/sj.leu.2404316","article-title":"Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features","volume":"20","author":"Wang","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2010.01.002_bib44","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1182\/blood-2006-05-022491","article-title":"High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count >600\u00d7109\/L) and ringed sideroblasts more than 15% considered as MDS\/MPD, unclassifiable","volume":"109","author":"Gattermann","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12308-008-0014-8","article-title":"The implication of identifying JAK2 (V617F) in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis","volume":"1","author":"Olsen","year":"2008","journal-title":"J Hematop"},{"key":"10.1016\/j.blre.2010.01.002_bib46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12185-008-0169-1","article-title":"Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status","volume":"88","author":"Raya","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2010.01.002_bib47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3324\/haematol.11581","article-title":"JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis","volume":"93","author":"Schmitt-Graeff","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2010.01.002_bib48","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.leu.2404909","article-title":"Detection of an MPLW515 mutation in a case with features of both essential thrombocythemia and refractory anemia with ringed sideroblasts and thrombocytosis","volume":"22","author":"Schnittger","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2010.01.002_bib49","doi-asserted-by":"crossref","unstructured":"Sokol L, Caceres G, Rocha K, Stockero KJ, Dewald DW, List AF. JAK2(V617F) mutation in myelodysplastic syndrome (MDS) with del(5q) arises in genetically discordant clones. Leuk Res 2009 Oct 8 [epub ahead of print].","DOI":"10.1016\/j.leukres.2009.09.016"},{"key":"10.1016\/j.blre.2010.01.002_bib50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2405030","article-title":"Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes","volume":"22","author":"Buesche","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2010.01.002_bib51","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1992.tb02982.x","article-title":"A predictive model for the clinical response to low dose ara-C: a study of 102 patients with myelodysplastic syndromes or acute leukaemia","volume":"81","author":"Hellstrom-Lindberg","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.01.002_bib52","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1200\/JCO.2008.18.2246","article-title":"Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes","volume":"27","author":"Della Porta","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2010.01.002_bib53","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.humpath.2007.10.034","article-title":"Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative disorders with JAK2 V617F","volume":"39","author":"Gibson","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.blre.2010.01.002_bib54","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/leu.2008.249","article-title":"UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation","volume":"23","author":"Szpurka","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2010.01.002_bib55","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood-2009-03-210039","article-title":"Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies","volume":"114","author":"Abdel-Wahab","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib56","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2010.01.002_bib57","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1182\/blood-2009-02-205690","article-title":"Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic\/myeloproliferative neoplasms","volume":"113","author":"Jankowska","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib58","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1182\/blood-2009-04-215814","article-title":"TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)","volume":"114","author":"Kosmider","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib59","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3324\/haematol.2009.011205","article-title":"TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia","volume":"94","author":"Kosmider","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2010.01.002_bib60","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.391","article-title":"Acquired mutations in TET2 are common in myelodysplastic syndromes","volume":"41","author":"Langemeijer","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.blre.2010.01.002_bib61","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1200\/JCO.2009.22.6985","article-title":"Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome","volume":"27","author":"Mohamedali","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2010.01.002_bib62","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/leu.2009.59","article-title":"Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS\/MPN and AML","volume":"23","author":"Tefferi","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2010.01.002_bib63","doi-asserted-by":"crossref","unstructured":"Flach J, Dicker F, Schnittger S, Kohlmann A, Haferlach T, Haferlach C. Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis (RARS-T). Haematologica 2009 Nov 10 [epub ahead of print].","DOI":"10.3324\/haematol.2009.013631"},{"key":"10.1016\/j.blre.2010.01.002_bib64","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.blre.2010.01.002_bib65","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1158\/0008-5472.CAN-08-2754","article-title":"250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies","volume":"68","author":"Dunbar","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2010.01.002_bib66","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1200\/JCO.2009.23.7503","article-title":"Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies","volume":"27","author":"Makishima","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2010.01.002_bib67","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1158\/1078-0432.CCR-08-1325","article-title":"CBL exon 8\/9 mutants activate the FLT3 pathway and cluster in core binding factor\/11q deletion acute myeloid leukemia\/myelodysplastic syndrome subtypes","volume":"15","author":"Reindl","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.blre.2010.01.002_bib68","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","article-title":"Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia","volume":"145","author":"Gelsi-Boyer","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.01.002_bib69","doi-asserted-by":"crossref","unstructured":"Boultwood J, Perry J, Pellagatti A, Fernandez-Mercado M, Fernandez-Santamaria C, Calasanz MJ, et al. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. Leukemia 2010, in press.","DOI":"10.1038\/leu.2010.20"},{"key":"10.1016\/j.blre.2010.01.002_bib70","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1365-2141.2003.04153.x","article-title":"A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin+granulocyte colony-stimulating factor: significant effects on quality of life","volume":"120","author":"Hellstrom-Lindberg","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.01.002_bib71","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood-2004-10-3872","article-title":"Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF","volume":"106","author":"Jadersten","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.01.002_bib72","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1200\/JCO.2007.15.4906","article-title":"Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome","volume":"26","author":"Jadersten","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2010.01.002_bib73","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/asheducation-2008.1.52","article-title":"The role of JAK2 mutations in RARS and other MDS","author":"Hellstrom-Lindberg","year":"2008","journal-title":"Hematology (Am Soc Hematol Educ Program)"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X10000032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X10000032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T06:31:01Z","timestamp":1590647461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X10000032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0268960X10000032"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2010.01.002","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}